BIOTECH: Firms see modest signs of investment rebound

SAN DIEGO —- Biotech’s golden allure is mostly tarnished for investors, who have crammed into the technology sector chasing after the Apples and Googles. But there are some signs of a modest turnaround, experts said Monday at a life sciences investors conference.

Biotech companies will have to squeeze to make every dollar count, and more mergers and acquisitions will take place for lack of any alternative, said panelists during a morning discussion.

The conference was sponsored by Biocom, the San Diego-based life sciences trade group. About 200 people attended to hear biotech companies, mostly from San Diego County, make a pitch for investments and partnerships.

Read more here